Nanobiotix (NBTX) Invested Capital (2018 - 2025)

Nanobiotix (NBTX) has 8 years of Invested Capital data on file, last reported at $111.0 million in Q4 2025.

• In Q4 2025, Invested Capital rose 103.99% year-over-year to $111.0 million; the TTM figure through Dec 2025 stood at $274.0 million (up 27.03% YoY), while the FY2025 annual figure was $107.7 million, up 95.48% from the prior year.
• Invested Capital climbed to $111.0 million in Q4 2025, from $54.4 million in the prior quarter.
• Across five years, Invested Capital topped out at $111.0 million in Q4 2025 and bottomed at $52.6 million in Q4 2021.
• A 5-year average of $65.3 million and a median of $54.4 million in 2024 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2021 — Invested Capital slipped 9.85% — and 2025, when it surged 103.99%.
• Year by year, Invested Capital stood at $52.6 million in 2021, then advanced by 3.04% to $54.2 million in 2022, then advanced by 0.29% to $54.4 million in 2023, then decreased by 0.02% to $54.4 million in 2024, then surged by 103.99% to $111.0 million in 2025.
• The last three Invested Capital figures came in at $111.0 million (Q4 2025), $54.4 million (Q4 2024), and $54.4 million (Q4 2023), per Business Quant data.

Peer Comparison